Radiation Safety Considerations for Emerging Therapeutic Radionuclides: From Manufacturing Supply to Patient Administration

1:30 pm - Wednesday 2nd December 2026

  • Understanding how radiation safety requirements differ between diagnostic and therapeutic radiopharmaceuticals, particularly as longer-lived radionuclides enter clinical use 
  • Exploring the key considerations for safely producing, handling and administering emerging therapeutic radionuclides across manufacturing and clinical environments 
  • Identifying the certification, compliance and operational requirements required to introduce new radionuclides into practice

Speakers:

PET Radiopharmacy Production & QC Analyst, Radiation Safety Supervisor
Curium Pharma